Choosing a course is one of the most important decisions you'll ever make! View our courses and see what our students and lecturers have to say about the courses you are interested in at the links below.
Each year more than 4,000 choose University of Galway as their University of choice. Find out what life at University of Galway is all about here.
About University of Galway
About University of Galway
Since 1845, University of Galway has been sharing the highest quality teaching and research with Ireland and the world. Find out what makes our University so special – from our distinguished history to the latest news and campus developments.
Colleges & Schools
Colleges & Schools
University of Galway has earned international recognition as a research-led university with a commitment to top quality teaching across a range of key areas of expertise.
- Research & Innovation
Business & Industry
Guiding Breakthrough Research at University of Galway
We explore and facilitate commercial opportunities for the research community at University of Galway, as well as facilitating industry partnership.
- Alumni & Friends
At University of Galway, we believe that the best learning takes place when you apply what you learn in a real world context. That's why many of our courses include work placements or community projects.
November 2015 €4 Million Secured by REMODEL at CURÁM for Tendon Repair and Regeneration Research
€4 Million Secured by REMODEL at CURÁM for Tendon Repair and Regeneration Research
Consortium led by NUI Galway will develop the world’s first three-dimensional, cell-assembled prototype for human and equine patients suffering tendon injuries
The Regenerative, Modular and Developmental Engineering Laboratory (REMODEL), part of the Centre for Research in Medical Devices (CÚRAM), at NUI Galway, has secured almost €4 million for the development of an advanced therapy medicinal product (ATMP) for tendon repair and regeneration. The project will train 15 early stage researchers in the multidisciplinary field of ATMPs, enhancing European competiveness in this sector.
Advanced therapy medicinal products are medicines for human use that are based on genes or cells. They offer ground breaking opportunities for the treatment of disease and injury. ATMPs can include tissue engineered medicines or a combination of one or more medical devices as an integral part of the medicine, for example, cells embedded in a biodegradable matrix or scaffold.
The funding was awarded through the Horizon 2020 grant programme, under the Marie Skłodowska-Curie European Training Networks action. This is the fourth such project being carried out by CÚRAM associated researchers to be funded under this programme. The project, called Tendon Therapy Train, will exploit recent advancements in the process by which cells are grown in controlled conditions, to develop the world’s first three-dimensional, cell-assembled prototype for human and equine patients suffering tendon injuries. The Tendon Therapy Train consortium is led by NUI Galway and is further comprised of six academics, three clinicians and seven industry partners.
Over 30 million human tendon-related procedures take place annually worldwide, with an estimated healthcare expenditure in excess of €145 billion per year. In addition, 46% of racehorses suffer from tendon-related injuries which impacts heavily on an industry which is valued at €100 billion in Europe and US$ 300 billion in the US. Current surgical interventions don’t always work effectively and can hinder normal tissue remodelling and function, which creates the need for new functional and clinically viable regeneration strategies.
Dr Dimitrios Zeugolis, REMODEL director and consortium lead at NUI Galway, said: “The driving hypothesis of this research is that replacement, repair and restoration of impaired tissue function can be accomplished best by using the cells’ own ability to create highly sophisticated structures with a precision and efficiency still unmatched by human-made devices.”
Further, Dr Zeugolis pointed out that, “The Marie Skłodowska-Curie Innovative Training Networks award will train a cohort of 15 researchers to doctoral level in the area of ATMPs which involves numerous disciplines, equipping them with transferable skills in each discipline that will further European-based knowledge, innovation, competitiveness and leadership in this field.”
Speaking about the award, Professor Abhay Pandit, Director of CÚRAM, said: “Tendon Therapy Train is an indicative example of the clinically relevant, cutting-edge research and innovation conducted here at NUI Galway. We are delighted to have secured funding yet again for this highly competitive award.”
CÚRAM is the National Centre for Research in Medical Devices, funded by Science Foundation Ireland, with the goal of radically improving health outcomes for patients with chronic illnesses.